Literature DB >> 31558665

Functional assessment of glucocerebrosidase modulator efficacy in primary patient-derived macrophages is essential for drug development and patient stratification.

Natalie J Welsh1, Christina A Gewinner1, Kavita Mistry2, Mumta Koglin2, Juniebel Cooke3, Matthew Butler1, Ben Powney2, Malcolm Roberts2, James M Staddon2, Anthony H V Schapira4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31558665      PMCID： PMC7193507          DOI： 10.3324/haematol.2019.224717

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  21 in total

1.  Phenotype, diagnosis, and treatment of Gaucher's disease.

Authors:  Gregory A Grabowski
Journal:  Lancet       Date:  2008-10-04       Impact factor: 79.321

Review 2.  Gaucher's disease.

Authors:  E Beutler
Journal:  N Engl J Med       Date:  1991-11-07       Impact factor: 91.245

Review 3.  Gaucher disease and its treatment options.

Authors:  Lunawati L Bennett; Devipriya Mohan
Journal:  Ann Pharmacother       Date:  2013-09       Impact factor: 3.154

Review 4.  Improving and accelerating drug development for nervous system disorders.

Authors:  Diana E Pankevich; Bruce M Altevogt; John Dunlop; Fred H Gage; Steve E Hyman
Journal:  Neuron       Date:  2014-11-05       Impact factor: 17.173

5.  Identification and characterization of ambroxol as an enzyme enhancement agent for Gaucher disease.

Authors:  Gustavo H B Maegawa; Michael B Tropak; Justin D Buttner; Brigitte A Rigat; Maria Fuller; Deepangi Pandit; Liangiie Tang; Gregory J Kornhaber; Yoshitomo Hamuro; Joe T R Clarke; Don J Mahuran
Journal:  J Biol Chem       Date:  2009-07-03       Impact factor: 5.157

Review 6.  Gaucher disease: mutation and polymorphism spectrum in the glucocerebrosidase gene (GBA).

Authors:  Kathleen S Hruska; Mary E LaMarca; C Ronald Scott; Ellen Sidransky
Journal:  Hum Mutat       Date:  2008-05       Impact factor: 4.878

7.  The uptake of iron by reticulocytes. The influence of purification of the ghosts on iron-containing components in the ghost suspension.

Authors:  C von der Heul; M J Kroos; C M de Jeu-Jaspars; H G von Eijk
Journal:  Biochim Biophys Acta       Date:  1980-10-02

Review 8.  The relationship between glucocerebrosidase mutations and Parkinson disease.

Authors:  Anna Migdalska-Richards; Anthony H V Schapira
Journal:  J Neurochem       Date:  2016-02-10       Impact factor: 5.372

Review 9.  The role of glucocerebrosidase in Parkinson disease pathogenesis.

Authors:  Matthew E Gegg; Anthony H V Schapira
Journal:  FEBS J       Date:  2018-02-19       Impact factor: 5.542

10.  Glucocerebrosidase deficiency in substantia nigra of parkinson disease brains.

Authors:  Matthew E Gegg; Derek Burke; Simon J R Heales; J Mark Cooper; John Hardy; Nicholas W Wood; Anthony H V Schapira
Journal:  Ann Neurol       Date:  2012-09       Impact factor: 10.422
View more
  1 in total

1.  Comparative Transcriptome Analysis in Monocyte-Derived Macrophages of Asymptomatic GBA Mutation Carriers and Patients with GBA-Associated Parkinson's Disease.

Authors:  Tatiana Usenko; Anastasia Bezrukova; Katerina Basharova; Alexandra Panteleeva; Mikhail Nikolaev; Alena Kopytova; Irina Miliukhina; Anton Emelyanov; Ekaterina Zakharova; Sofya Pchelina
Journal:  Genes (Basel)       Date:  2021-09-29       Impact factor: 4.096
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.